Thumbnail Image
Publication

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.

Hoskin, P
; 
Kirkwood, A
; 
Popova, B
; 
Smith, P
; 
Robinson, M
; 
Gallop-Evans, E
; 
Coltart, S
; 
Illidge, Timothy M
; 
Madhavan, K
; 
Brammer, C
... show 3 more
Citations
Altmetric:
Abstract
Follicular lymphoma has been shown to be highly radiosensitive with responses to doses as low as 4 Gy in two fractions. This trial was designed to explore the dose response for follicular lymphoma comparing 4 Gy in two fractions with 24 Gy in 12 fractions METHODS: FORT is a prospective randomised, unblinded, phase 3 non-inferiority study comparing radiotherapy given as 4 Gy in two fractions with a standard dose of 24 Gy in 12 fractions. Entry criteria included all patients aged over 18 years, having local radiotherapy for radical or palliative local control, with follicular lymphoma or marginal zone lymphoma, who had received no previous treatment for at least 1 month before. The primary outcome was time to local progression analysed on an intention-to-treat basis. Randomisation was centralised through the Cancer Research UK and University College London Cancer Trials Centre. Radiotherapy target sites were randomised (1:1) with minimisation stratified by histology (follicular lymphoma vs marginal zone lymphoma), treatment intent (palliative or curative) and centre. This trial is registered with ClinicalTrials.gov number, NCT00310167.
Authors
Hoskin, P
Kirkwood, A
Popova, B
Smith, P
Robinson, M
Gallop-Evans, E
Coltart, S
Illidge, Timothy M
Madhavan, K
Brammer, C
Diez, P
Jack, A
Syndikus, I
Affiliation
Description
Date
2014-02-21
Publisher
Collections
All Christie Publications
Load more
Show all metadata
Keywords
Type
Article
Citation
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. 2014: Lancet Oncol
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/314865
Embedded videos